Accordingly, we analysed phospho-EGFR and EGFR expression in a large series of stage II and III colon cancers from completed 5-fluorouracil-based adjuvant therapy trials (O'Connell et al, 2006). This evidence concerns the gene EGFR and malignant colon neoplasm.